TLR 4 / MD2 Complex inhibitors potential therapeutic prospective for asthma and asthma exacerbation
The feedback of our body to foreign particles is initially initiated by the innate immunity where the likes Toll- Like Receptors (TLRs), play an important role in the identification process. The identification of the trouble through the interaction of the receptor is the initial step to propagate the protective agents throughout the body. These interact action with the attacking pathogens like viruses and bacteria (PAMPs, pathogen-associated molecular patterns) or substances produced cells of the body which are injured (DAMPs, danger-associated molecular patterns) helping in the identification. However, the innate and adaptive immunity of both of them gets stimulated through the release of various substances such as cytokines and chemokines due to TLR activation. In part of the progress, many reports have been identified as the activation of the TLR4 complex, a receptor of the innate immune system that may underpin the pathophysiology of many human diseases including asthma, cardiovascular disorder, diabetes, obesity, metabolic syndrome, autoimmune disorders, neuroinflammatory and psychiatric disorders. Substances of synthetic and natural origin have been discussed here and have been found to produce the anti-inflammatory effect by targeting pathways of TLR4 activation. In the present review, our focus is to develop a conclusion about the TL4 complex inhibition for the betterment of asthma patients and combine the reports about the progressing of TLR signalling pathway modulators.